Tetanus immunoglobulin

Active ingredient description

Human tetanus immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against the toxin produced by the bacteria clostridium tetanus.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J06BB02 Tetanus immunoglobulin J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB02

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
HUMAN TETANUS IMMUNOGLOBULIN Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
HYPERTET Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old

External identifiers

DrugBank Drug: DB11604
KEGG Drug: D08801
RxNorm Ingredient: 1727875
SNOMED-CT Concept: 425682001
Tetanus immunoglobulin (substance)
UNII Identifier: V4SWI4RF4J
HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.